Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Trump Backs Psychedelic Research

MONDAY, April 20, 2026 Psychedelic drugs could soon play a larger role in mental health care. Over the weekend, President Donald Trump signed an executive order

Report Finds Drug Prices Rising Despite Trump Pricing Deals

MONDAY, April 20, 2026 A new U.S. Senate report, released by Sen. Bernie Sanders, found that drug companies involved in price deals with President Donald Trump

AIDS Relief Program Sees Drops in Testing and Diagnoses After Disruptions

MONDAY, April 20, 2026 New data released Friday show that President s Emergency Plan for AIDS Relief (PEPFAR) treated about the same number of people in the las

SIR: Minimally Invasive Prostate Cancer Treatment Shows Faster Recovery Than Robotic Prostatectomy

Magnetic resonance imaging (MRI)-guided transurethral ultrasound ablation (TULSA) shows better initial perioperative outcomes than robotic prostatectomy (RP) fo

Smoking More Common in People With Chronic Pain

People who experience chronic pain tend to use cigarettes and electronic cigarettes (e-cigarettes) at higher rates than those without chronic pain, according to

Polysubstance, Opioid-Related Overdose Deaths Rose From 2004 to 2022

Overdose deaths from polysubstance use escalated from 2004 to 2022 for all racial and ethnic groups but with disproportionate increases for non-Hispanic Black a

Naloxone Has Limitations for Reversing ODs From Fentanyl, Sufentanil

Naloxone has limitations for reversing overdoses from fentanyl and sufentanil, gradually reversing respiratory depression, but with variable reversal times, acc

Study Looks at CRC Risk, Non-CRC Mortality in Seniors With Prior Adenoma

Older adults with adenoma at prior colonoscopy are more likely to experience subsequent colorectal cancer (CRC), but the cumulative risks are exceeded by compet

Ifinatamab Deruxtecan Granted Priority Review in the U.S. for Adult Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer who Experienced Disease Progression on or After Platinum-Based Chemotherapy

Daiichi Sankyo (TSE 4568) and Merck s (NYSE MRK), known as MSD outside of the United States and Canada, Biologics License Application (BLA) for ifinatamab derux

Lilly's Jaypirca (pirtobrutinib) Significantly Extended Progression-Free Survival When Added to a Venetoclax Time-Limited Regimen in Patients with Previously Treated CLL/SLL

Eli Lilly and Company (NYSE LLY) today announced positive topline results from the Phase 3 BRUIN CLL-322 trial of Jaypirca (pirtobrutinib), a non-covalent (reve

Popular Keywords